AI filing briefs · archive

8-K filings in September 2025, explained

427 material Form 8-K filings that 376 companies we cover made with the SEC in September 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

7 of 427 briefs match

newest first · times in ET
CDNSCADENCE DESIGN SYSTEMS INC Sep 4, 4:32 PM ET

Cadence to buy Hexagon's design and engineering unit for €2.70 billion

Neutral m&a Written later 1.013.02

Cadence Design Systems agreed on September 4, 2025 to acquire the design and engineering business of Hexagon Smart Solutions AB for an enterprise value of €2.70 billion, including about €810 million paid in newly issued Cadence common stock. Closing is expected in the first quarter of 2026 and is subject to antitrust and foreign investment approvals, and Cadence would owe a reverse termination fee of up to €175 million if regulatory approvals fail.

  • Enterprise value of €2.70 billion, with about €1.89 billion paid in cash and about €810 million in Cadence stock
  • Cash portion to be funded from cash on hand and borrowings under existing debt facilities
  • Closing expected in the first quarter of 2026; outside date September 4, 2026, extendable to March 4, 2027
  • Reverse termination fee of up to €175 million payable by Cadence in certain regulatory failure scenarios
Read the filing on SEC.gov ↗

Quanex posts $276.0 million Q3 loss on $302.3 million goodwill impairment

Mixed earnings Written later 2.02

Quanex reported net sales of $495.3 million for the quarter ended July 31, 2025, up 76.7% from a year earlier, mainly due to the Tyman acquisition. A $302.3 million non-cash goodwill impairment tied to the re-segmentation of the business drove a net loss of $276.0 million, or $6.04 per diluted share, compared with net income of $25.4 million a year earlier. The company also updated its fiscal 2025 guidance to about $1.82 billion in net sales and about $235 million in Adjusted EBITDA.

  • Q3 net sales $495.3 million, up from $280.3 million; excluding Tyman, sales rose 1.4%
  • Net loss of $276.0 million, or $6.04 per diluted share, versus $0.77 per share a year earlier
  • Adjusted diluted EPS $0.69 versus $0.81 a year earlier; Adjusted EBITDA $70.3 million
  • Fiscal 2025 guidance: net sales of approximately $1.82 billion and Adjusted EBITDA of approximately $235 million
Read the filing on SEC.gov ↗
LULUlululemon athletica inc. Sep 4, 4:10 PM ET

lululemon Q2 revenue up 7% to $2.5 billion, EPS $3.10 vs $3.15; outlook revised

Mixed earnings Written later 2.02

lululemon reported second-quarter fiscal 2025 revenue up 7% to $2.5 billion, but diluted EPS fell to $3.10 from $3.15 a year earlier and operating income declined 3%. The company revised its full-year outlook, now expecting 2025 revenue of $10.850 billion to $11.000 billion and diluted EPS of $12.77 to $12.97, citing U.S. business underperformance and an estimated $240 million gross profit reduction from tariffs.

  • Q2 net revenue rose 7% to $2.5 billion; Americas comparable sales fell 4% and international comparable sales rose 15%.
  • Q2 gross margin fell 110 basis points to 58.5%; operating margin fell 210 basis points to 20.7%.
  • Full-year 2025 EPS guidance is $12.77 to $12.97; third-quarter EPS is expected at $2.18 to $2.23.
  • Inventories rose 21% to $1.7 billion, and cash and equivalents stood at $1.2 billion at quarter end.
Read the filing on SEC.gov ↗
TTCTORO CO Sep 4, 8:46 AM ET

Toro Q3 sales fall 2%, reported EPS drops 53%; outlook at low end of prior ranges

Mixed guidance Written later 2.02

The Toro Company reported fiscal 2025 third-quarter net sales of $1.13 billion, down 2% from a year earlier, and reported diluted EPS of $0.54 versus $1.14, after an $81 million non-cash impairment charge tied to the Spartan business. Adjusted diluted EPS rose 5% to $1.24, but management now expects full-year net sales and adjusted diluted EPS at the lower end of prior guidance ranges.

  • Q3 net sales $1.13 billion, down 2%; Residential segment net sales down 27.9% to $192.8 million
  • Q3 reported diluted EPS $0.54 vs. $1.14; adjusted diluted EPS $1.24 vs. $1.18, up 5%
  • Fiscal 2025 guidance: net sales flat to down 3%, adjusted diluted EPS of about $4.15, at the lower end of prior ranges
  • AMP cost program: $75 million in annualized savings today, targeting at least $100 million by 2027
Read the filing on SEC.gov ↗
GPCGENUINE PARTS CO Sep 4, 8:43 AM ET

Genuine Parts signs Elliott cooperation agreement, adds two independent directors

Neutral leadership Written later 1.015.027.01

Genuine Parts Company entered into a Cooperation Agreement with Elliott Investment Management and appointed Matthew A. Carey and Court D. Carruthers to its Board effective September 4, 2025, while directors John R. Holder and Robin C. Loudermilk, Jr. retired. The filing also discloses new retention restricted stock units and a form of severance agreement for executives, which shareholders may weigh as part of the company's governance changes.

  • Carey and Carruthers joined the Board as independent directors, with initial terms expiring at the 2026 annual meeting; Carey joined the Audit Committee and Carruthers joined the Compensation and Human Capital Committee.
  • Holder and Loudermilk retired from the Board effective September 4, 2025, and the company said their decisions were not due to any disagreement with the company.
  • Retention RSU grants have a grant date value of $3.0 million for CEO Will Stengel and $1.5 million for each of CFO Bert Nappier, Naveen Krishna and Christopher Galla, cliff vesting on the third anniversary of the grant date.
  • The cooperation period runs until the earlier of 30 days before the 2027 annual meeting nomination deadline or September 4, 2026.
Read the filing on SEC.gov ↗

G-III Apparel Q2 sales fell 5% to $613.3 million; EPS $0.25; FY2026 outlook updated

Negative earnings Written later 2.02

G-III Apparel reported second-quarter fiscal 2026 net sales of $613.3 million, down 5% from a year earlier, and net income of $10.9 million, or $0.25 per diluted share, versus $0.53 a year earlier. It also updated fiscal 2026 guidance, now projecting net income of $112.0 million to $122.0 million, well below the $193.6 million reported for fiscal 2025, citing the macro environment, a more cautious outlook from retail partners and tariffs.

  • Q2 net sales of $613.3 million, down 5% from $644.8 million; net income of $10.9 million, or $0.25 per diluted share, versus $24.2 million, or $0.53, a year earlier.
  • Fiscal 2026 net income expected at $112.0 million to $122.0 million, or $2.53 to $2.73 per diluted share, versus $193.6 million, or $4.20, in fiscal 2025.
  • Estimated incremental tariff cost of approximately $155 million; remaining unmitigated impact of $75 million is reflected in fiscal 2026 guidance.
  • Repurchased 1,140,988 shares for $24.6 million in the second quarter; total debt was $15.5 million at July 31, 2025, versus $414.0 million a year earlier.
Read the filing on SEC.gov ↗
NGVTIngevity Corp Sep 4, 6:45 AM ET

Ingevity to sell CTO refinery and industrial specialties unit to Mainstream Pine for $110 million

Neutral m&a Written later 1.017.01

Ingevity agreed on September 3, 2025, to sell substantially all assets of its industrial specialties product line and its North Charleston crude tall oil refinery to Mainstream Pine Products for $110 million in cash, plus up to $19 million in contingent payments tied to future EBITDA. The company expects the deal to close by early 2026 and says it will reaffirm its full-year 2025 guidance, adjusted for reclassifying the sold assets as discontinued operations.

  • Cash purchase price of $110 million, subject to working capital adjustments, plus contingent consideration of $0 to $19 million
  • Ingevity expects 2025 revenue from the assets being sold to be about $130 million, with EBITDA margins in the low-to-mid single digits
  • Closing expected by early 2026; either party may terminate if the deal is not closed by January 31, 2026
  • Ingevity affirms 2025 guidance of sales of $1.25 billion to $1.40 billion and adjusted EBITDA of $390 million to $415 million, excluding the reclassification
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.